VolitionRX Limited Common Stock (NY:VNRX)

0.1975 UNCHANGED

Delayed Quote Updated: 8:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VolitionRX Limited Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Is Ambrx Biopharma (AMAM) Stock Down 15% Today? ↗

February 17, 2023

Ambrx Biopharma (AMAM) stock is falling on Friday but it's not due to any negative news released by the medical company today.

Via InvestorPlace

Why Is VolitionRX (VNRX) Stock Down 17% Today? ↗

February 17, 2023

VolitionRX (VNRX) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares.

Via InvestorPlace

Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket ↗

February 17, 2023

Gainers Ibio Inc (NYSE: IBIO) shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 17, 2023

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

VolitionRX's Return On Capital Employed Insights ↗

December 27, 2022

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences

February 14, 2023

Via ACCESSWIRE

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 09, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 ↗

February 01, 2023

Via Benzinga

Sidoti's January Micro-Cap Conference

January 17, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗

December 19, 2022

Via Benzinga

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗

October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...

Via Benzinga

Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics

October 11, 2022

Via ACCESSWIRE

Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session ↗

October 20, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 27, 2022

On Tuesday, 456 stocks hit new 52-week lows.

Via Benzinga

Sidoti's August Micro-Cap Virtual Conference

August 16, 2022

Via ACCESSWIRE

Around $1.1 Million Bet On Ring Energy? Check Out These 3 Penny Stocks Insiders Are Buying ↗

August 05, 2022

U.S. crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer

August 02, 2022

Via ACCESSWIRE

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗

July 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗

August 01, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...

Via Benzinga

Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session ↗

July 29, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.

Via Benzinga

Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket ↗

July 29, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.

Via Benzinga

Looking Into VolitionRX's Return On Capital Employed ↗

June 16, 2022

According to data from Benzinga Pro, during Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $114.21 thousand. Despite a 4.81% increase in earnings, the company posted a loss of $7.72 million.

Via Benzinga

Recap: VolitionRX Q1 Earnings ↗

May 11, 2022

VolitionRX (AMEX:VNRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings VolitionRX missed estimated earnings...

Via Benzinga

A Preview Of VolitionRX's Earnings ↗

May 10, 2022

VolitionRX (AMEX:VNRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that VolitionRX will...

Via Benzinga

VolitionRX Earnings Perspective: Return On Capital Employed ↗

March 31, 2022

Benzinga Pro data, VolitionRX (AMEX:VNRX) reported Q4 sales of $14.24 thousand. Earnings fell to a loss of $8.11 million, resulting in a 12.9% decrease from last quarter.

Via Benzinga

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗

December 14, 2021

Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Sidoti December Micro Cap Virtual Conference

December 07, 2021

Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation...

From Sidoti & Company, LLC

Via AccessWire

Sidoti Microcap Virtual Conference

November 05, 2021

A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 /...

From Sidoti & Company, LLC

Via AccessWire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.